Review Article
Malignant Pleural Effusion: Diagnosis and Management
Table 1
A prognostic score for malignant pleural effusions (LENT) [
33].
| | Variable | Score |
| L | LDH in pleural fluid | | <1,500 UI/L | 0 | >1,500 UI/L | 1 |
| E | ECOG performance score | | 0 | 0 | 1 | 1 | 2 | 2 | 3-4 | 3 |
| N | Neutrophil/lymphocyte ratio | | <9 | 0 | >9 | 1 |
| T | Type of tumour | | Low risk (mesothelioma and hematologic malignancies) | 0 | Moderate risk (breast cancer, gynecological, and renal cell carcinoma) | 1 | High risk (lung cancer and other tumours) | 2 | Risk by category | Total score | Low risk (median of survival: 319 days) | 0-1 | Moderate risk (median of survival: 130 days) | 2–4 | High risk (median of survival: 44 days) | 5–7 |
|
|
ECOG, eastern cooperative oncology group; LDH, lactate dehydrogenase.
|